These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37380984)

  • 21. Analysis and Validation of TMED3 correlates with poor prognosis and tumor immune infiltration of glioma.
    Liao G; Zhang M; Wang C
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3485-3494. PubMed ID: 35951089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
    Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
    BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CCL8 as a promising prognostic factor in diffuse large B-cell lymphoma
    Lou X; Zhao K; Xu J; Shuai L; Niu H; Cao Z; Wang J; Zhang Y
    Front Immunol; 2022; 13():950213. PubMed ID: 36072582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrated genomic, transcriptomic, and epigenetic analyses identify a leukotriene synthesis-related M2 macrophage gene signature that predicts prognosis and treatment vulnerability in gliomas.
    Ji H; Liu Z; Wang N; Jin J; Zhang J; Dong J; Wang F; Yan X; Gong Q; Zhao H; Sun H; Li Y; Hu S; You C
    Front Immunol; 2022; 13():970702. PubMed ID: 36159811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pyroptosis-related signature predicts prognosis and indicates immune microenvironment infiltration in glioma.
    Chen J; Chen S; Li B; Zhou S; Lin H
    Cancer Med; 2023 Feb; 12(4):5071-5087. PubMed ID: 36161280
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Ma W; Zhang K; Bao Z; Jiang T; Zhang Y
    Front Immunol; 2021; 12():659659. PubMed ID: 33936093
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Yu M; Chang Y; Zhai Y; Pang B; Wang P; Li G; Jiang T; Zeng F
    Front Immunol; 2022; 13():1089266. PubMed ID: 36713360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MXRA5 Is a Novel Immune-Related Biomarker That Predicts Poor Prognosis in Glioma.
    Sun JZ; Zhang JH; Li JB; Yuan F; Tong LQ; Wang XY; Chen LL; Fan XG; Zhang YM; Ren X; Zhang C; Yu SP; Yang XJ
    Dis Markers; 2021; 2021():6680883. PubMed ID: 34211612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive value of PIMREG in the prognosis and response to immune checkpoint blockade of glioma patients.
    Zhu H; Hu X; Feng S; Gu L; Jian Z; Zou N; Xiong X
    Front Immunol; 2022; 13():946692. PubMed ID: 35928818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PLEKHA4 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Glioma.
    Zhang W; Li L; Bian PP; Luo QP; Xiong ZT
    Biomed Res Int; 2023; 2023():4504474. PubMed ID: 36714030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic Gene Expression Signature in Patients With Distinct Glioma Grades.
    Ait Ssi S; Chraa D; El Azhary K; Sahraoui S; Olive D; Badou A
    Front Immunol; 2021; 12():685213. PubMed ID: 34539626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced B7-H4 expression in gliomas with low PD-L1 expression identifies super-cold tumors.
    Chen D; Li G; Ji C; Lu Q; Qi Y; Tang C; Xiong J; Hu J; Yasar FBA; Zhang Y; Hoon DSB; Yao Y; Zhou L
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32457124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive exploration of tumor mutational burden and immune infiltration in diffuse glioma.
    Kang K; Xie F; Wu Y; Wang Z; Wang L; Long J; Lian X; Zhang F
    Int Immunopharmacol; 2021 Jul; 96():107610. PubMed ID: 33848908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune cell gene expression signatures in diffuse glioma are associated with IDH mutation status, patient outcome and malignant cell state, and highlight the importance of specific cell subsets in glioma biology.
    Mehani B; Asanigari S; Chung HJ; Dazelle K; Singh A; Hannenhalli S; Aldape K
    Acta Neuropathol Commun; 2022 Feb; 10(1):19. PubMed ID: 35144680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioinformatic Profiling of Prognosis-Related Genes in Malignant Glioma Microenvironment.
    Li Y; Deng G; Qi Y; Zhang H; Gao L; Jiang H; Ye Z; Liu B; Chen Q
    Med Sci Monit; 2020 Aug; 26():e924054. PubMed ID: 32843610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased Vascular Adhesion Protein 1 (VAP-1) Levels are Associated with Alternative M2 Macrophage Activation and Poor Prognosis for Human Gliomas.
    Chang SJ; Tu HP; Lai YC; Luo CW; Nejo T; Tanaka S; Chai CY; Kwan AL
    Diagnostics (Basel); 2020 Apr; 10(5):. PubMed ID: 32349342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of a nine-gene signature in glioma patients based on tumor-associated macrophages expression profiling.
    Shan X; Zhang C; Wang Z; Wang K; Wang J; Qiu X; Jiang T; Yang P
    Clin Immunol; 2020 Jul; 216():108430. PubMed ID: 32325251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ABCD3 is a prognostic biomarker for glioma and associated with immune infiltration: A study based on oncolysis of gliomas.
    Li J; Zhang Y; Qu Z; Ding R; Yin X
    Front Cell Infect Microbiol; 2022; 12():956801. PubMed ID: 35959373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Significance of mRNA Expression RBBP8 or Its Methylation in Gliomas.
    Liu Z; Cheng X; Lin S; Han Z; Jin H; Luan Z; Li P; Liang W; Qian R; Gao Y
    Cell Mol Neurobiol; 2023 Jan; 43(1):409-422. PubMed ID: 35106666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoxia promotes glioma-associated macrophage infiltration via periostin and subsequent M2 polarization by upregulating TGF-beta and M-CSFR.
    Guo X; Xue H; Shao Q; Wang J; Guo X; Chen X; Zhang J; Xu S; Li T; Zhang P; Gao X; Qiu W; Liu Q; Li G
    Oncotarget; 2016 Dec; 7(49):80521-80542. PubMed ID: 27602954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.